NCT07164950View on ClinicalTrials.gov

Compression Stockings to Prevent Peripheral Neuropathy Caused by Antibody-Drug Conjugates in Urothelial Carcinoma Patients

NARecruitingINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

August 30, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

July 1, 2026

Conditions
Urothelial CarcinomaAdvanced Solid TumorsChemotherapy-Induced Peripheral NeuropathyAntibody-drug Conjugates
Interventions
DEVICE

Medical-grade compression stocking

A knee-high compression stocking providing 20-30 mmHg pressure will be applied to the assigned foot during the ADC treatment period to prevent chemotherapy-induced peripheral neuropathy (CIPN). Stockings will be worn daily, except during bathing.

Trial Locations (1)

Unknown

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Sheng Zhang

OTHER

NCT07164950 - Compression Stockings to Prevent Peripheral Neuropathy Caused by Antibody-Drug Conjugates in Urothelial Carcinoma Patients | Biotech Hunter | Biotech Hunter